ABOUT US
WHO WE ARE
We are a R&D company focusing on developing groundbreaking science and technology for fulfilling unmet need in health and medicine. We are developing innovative technologies for diagnosis and therapy for patients with severe retinal/neurodegenerative diseases.
Our mission is to discover, incubate and translate next generation biomedical technologies, empowered by the experienced and dedicated team of scientists and support staffs. Our scientific endeavour is supported by a strong management and commercialization team with extensive experience.
We have established strong collaborations with esteemed academic institutions and industrial partners to fulfill our mission.
Samarendra Mohanty (Founder, President and Chief Scientific Officer) is an inventor & serial entrepreneur with 20+ years experience in Biomedical Sciences. He is Co-Founder and Board member of several Biotechs and Biomedical device /diagnostic companies (developed & commercialized $100K+ biomedical instruments.) Samar obtained M.Tech in Applied Optics from the Indian Institute of Technology-Delhi and a PhD in (Bio)Physics from the Indian Institute of Sciences-Bangalore. His extensive Biomedical Technologies experience includes serving as Professor/Senior Scientist at the University of Texas; University of California, Irvine; Center for Adv. Tech (India); Int. Mol. Biotech (Germany); Univ. Pavia (Italy); NUS (Singapore); and University of St. Andrews (UK). He has authored over 200 international patents and publications in leading journals including Nature and Nature Photonics. He has served as Principal Investigator for major grants from the National Eye Institute including Audacious Goal Initiative and Bioengineering Research grants. He serves on the editorial board of journals and chairs an international conference on optogenetics. He is the winner of a 2019 Healthcare Heroes award (Fort Worth Business Press), Retinal Organoid Challenge Award, Audacious Goal Initiative Award (NIH), Finalist of Tech Titan award, and NIH-Director’s Innovator Award. He is chair of Nanoscope IACUC and IBC.
Samarendra Mohanty, Ph. D.
PRESIDENT
SCIENTIFIC LEADERSHIP TEAM
Sanghoon Kim, Ph. D.
Dr. Sang hoon Kim, Ph. D. has scientific expertise in optical imaging, spectroscopy, and interferometric technique. He earned his PhD in biomedical engineering and Bachelor of science in biomedical engineering and physics from Duke university. During his PhD tenure, Dr. Kim focused on development of multimodal optical systems guided by optical coherence tomography (OCT) to improve clinical diagnosis. Dr. Kim is interested in enhancing Nanoscope’s optical imaging platforms.
Adnan Dibas, Ph. D.
Dr. Adnan Dibas received PhD in Biochemistry from UNT Health Science Center and did Postdoctoral fellowship at St. Paul Medical center. He has over 20 years of experience in ocular research and a long-standing interest in therapies for glaucoma and neurodegeneration. Prior to joining Nanoscope, he was a professor at UNT HSC and has been Principal Investigator of grants from Brightfocus foundation and Galucoma Research Foundation.
Subrata Batabyal, Ph. D.
Dr. Subrata Batabyal’s scientific expertise spans across the areas of Biophysics, Biochemistry, Optics, Biomedical Instrumentation and Optogenetics. He earned PhD in Chemistry with focus on ultrafast laser spectroscopy to investigate biomolecular interaction. He is working on optical gene delivery and label-free detection of retinal and cortical neuronal activity for early diagnosis of visual disorders.